AD

Ajit Dattatray Shringarpure

Active Director Director DIN 09687668
DIN 09687668 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajit Dattatray Shringarpure

Data last updated:

Ajit Dattatray Shringarpure is a Director at Medverse Healthcare Private Limited (since 2022). The company operates in Healthcare.

DIN 09687668
Primary Designation Director
Industry Healthcare
First Appointment 27 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medverse Healthcare Private Limited U31900MH2022PTC387633
Director27 Jul 20222022Active

Board colleagues of Ajit Dattatray Shringarpure

Directorship timeline

Open interactive timeline →
Medverse Healthcare Private Limited
Premium access

Shareholding and investment profile for Ajit Dattatray Shringarpure

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajit Dattatray Shringarpure

Ajit Dattatray Shringarpure currently holds 1 directorship: Medverse Healthcare Private Limited (Director, since 27 Jul 2022).

Ajit Dattatray Shringarpure was first appointed on 27 Jul 2022 as Director at Medverse Healthcare Private Limited.

The current boards of Ajit Dattatray Shringarpure's companies include Mehul Deepak Chheda (Medverse Healthcare Private Limited), Vipul Ramji Gogri (Medverse Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available